Your Chief AI Officer Daily Brief

What AI and robotics can do this week, for the Chief Marketing Officer.

Patient acquisition, reputation, referral relationships, content, the digital front door and how AI changes the relationship with patients and referrers rather than only the funnel. Every item below carries a line written for this seat. Subscribe and the weekday brief arrives ordered for it.

Reported5 sourcesFor patientsWednesday, November 11, 2026

Chief AI OfficerCEOCMO (marketing)CMO (medical)

Oura agrees to buy AI primary care company Counsel Health for $625 million

Oura agreed to acquire Counsel Health for $625 million in cash, according to a Nov. 10 news release reported by Becker's. The deal combines Oura's continuous biometric monitoring with Counsel's medical AI platform and physician network. STAT notes that Oura recently delayed plans to go public. MedCity News asks whether payers and employers will cover the ring as a benefit, and whether consumers will pay for a more expensive subscription.

Do this week. Decide whether your primary care and wellness lines will accept, refer from or compete with wearable-led AI virtual care, and brief the board on that position. Run this

The claim.
Oura says the acquisition will combine continuous biometric monitoring with Counsel's medical AI and physician network to move from health tracking into clinical care.
The evidence.
No independent evidence on outcomes or cost exists yet, and MedCity News reports that payer and employer coverage remains an open question.

For the Chief Marketing Officer. Work out how you would stay the trusted clinical relationship for patients who also get AI-led care through a device app.

For the Chief AI Officer. Set a policy on whether and how patient-supplied wearable data and outside AI care summaries enter your record.

For the CEO and board. Treat a funded consumer device company that now has a physician network as a possible competitor or partner for primary care relationships.

Read the full item

Sources:Becker's Hospital ReviewSTAT Health TechMedCity NewsAthletech NewsHIT Consultant

Reported2 sourcesFor patientsMonday, November 2, 2026

Chief AI OfficerCMO (marketing)CompliancePatient experience

Pew finds 46% of Americans oppose AI in insurance claim decisions

A Pew Research Center survey published Oct. 29 found nearly half of U.S. adults oppose AI playing any role in health insurance claim decisions, according to Becker's Payer Issues. The survey of 3,488 adults, conducted in June, tested openness to AI across eight healthcare tasks. Separately, Healthcare IT Today reported that 91% of patients want their permission required when AI is used for diagnosis.

Do this week. Review where your organization discloses AI use to patients and members, starting with claims and diagnosis, and close the gaps. Run this

The evidence.
The Pew survey of 3,488 adults, as reported by Becker's, found 46% oppose any AI role in claim decisions; no independent evidence ties disclosure practices to trust outcomes yet.

For the Chief Marketing Officer. Prepare plain-language explanations of how AI is and is not used, so patients hear it from you rather than from a denial letter.

For the Chief AI Officer. Add patient disclosure and consent to the AI governance checklist for any tool touching claims or diagnosis.

For the Compliance, privacy and legal. Inventory current consent language against AI use in diagnosis and claims and flag where permission is not sought.

For the Patient experience. Brief contact center staff on how to answer patient questions about AI in claims and care decisions.

Read the full item

Sources:Becker's Payer IssuesHealthcare IT Today

Announced1 sourceFor patients and employeesMonday, November 2, 2026

Chief AI OfficerCMO (marketing)Compliance

OpenAI will honor a shared robots.txt signal for AI training preferences

OpenAI announced it will honor a shared robots.txt signal that lets website operators communicate their AI training preferences to participating providers.

Do this week. Decide whether your organization's patient education and clinical content should be available for AI training and set the robots.txt signal accordingly. Run this

The claim.
OpenAI says the signal helps website operators communicate training preferences to participating providers.
The evidence.
This is a company announcement; no independent evidence of adoption is available yet.

For the Chief Marketing Officer. Weigh whether having your patient content in AI training helps patients find accurate answers or weakens control of your voice.

For the Chief AI Officer. Set an organizational position on AI training use of public content and record it in governance policy.

For the Compliance, privacy and legal. Document the decision on training preferences alongside existing website terms.

Disclosure at publication: OpenAI is one of the enterprise AI platforms Ecofy implements for clients.

Read the full item

Sources:OpenAI News

Reported2 sourcesFor patients and employeesThursday, October 29, 2026

Chief AI OfficerCMO (medical)ComplianceCMO (marketing)

OpenAI sued over epilepsy death after ChatGPT allegedly advised drug taper

The parents of a 31-year-old Seattle woman with epilepsy filed a wrongful death suit against OpenAI and Sam Altman on Oct. 27 in San Francisco County Superior Court, Becker's reported. The complaint alleges she stopped antiseizure medication on a schedule ChatGPT designed. MedPage Today also covered the filing.

Do this week. Add a line to patient education and after-visit materials telling patients to confirm any medication change suggested by a chatbot with their care team. Run this

The claim.
The plaintiffs allege ChatGPT told the patient to stop taking her seizure medication; the allegations have not been tested in court.
The evidence.
Two outlets report the filing; no court finding exists.

For the Chief AI Officer. Brief the board that patients already use consumer chatbots for medication decisions and set a policy for how clinicians ask about it.

For the Chief Medical Officer and physicians. Ask clinicians to add chatbot use to medication reconciliation questions for patients on high-risk drugs.

For the Compliance, privacy and legal. Review whether any patient-facing AI you deploy can give dosing or taper instructions and document the guardrails.

Read the full item

Sources:Becker's Hospital ReviewMedPage Today

Reported1 sourceFor patients and employeesThursday, October 29, 2026

Chief AI OfficerPatient experienceCOOCMO (marketing)

Zocdoc opens appointment booking to AI agents acting for patients

Zocdoc is inviting AI agents to book appointments on behalf of patients, Healthcare Dive reported. CEO Dr. Oliver Kharraz called it a contrarian move while much of the industry remains wary of agentic AI.

Do this week. Decide whether your scheduling channels will accept agent-made bookings and how front-desk staff verify them. Run this

The claim.
Kharraz describes the move as contrarian relative to an industry still wary of agentic AI.
The evidence.
No independent evidence yet on booking accuracy or no-show rates for agent-made appointments.

For the Chief AI Officer. Set a policy for third-party agents that act on a patient's behalf, including identity and consent checks.

For the Patient experience. Test what a patient experiences when an agent books for them and where a human confirms.

Read the full item

Sources:Healthcare Dive

Opinion1 sourceFor patientsMonday, October 26, 2026

Chief AI OfficerPatient experienceCMO (marketing)

Researchers say long-term effects of chatbot use on isolation are unknown

In a STAT opinion piece, researchers argue that no one yet knows whether people gradually disconnect from one another over months of interacting with chatbots, and that researchers need better access to data to find out.

Do this week. Review any patient-facing chatbot you run or plan to run and add a clear handoff to a human and a way to measure repeat use. Run this

The claim.
The authors argue that cumulative chatbot use may affect social connection and that the data to study it is missing.
The evidence.
This is an opinion piece; the authors state that the evidence does not yet exist.

For the Chief AI Officer. Add usage and escalation monitoring to the governance requirements for patient-facing AI.

For the Patient experience. Make sure frequent chatbot users are offered contact with a person, especially in behavioral health and senior care.

Read the full item

Sources:STAT Health Tech